Skip to main content

Advertisement

Table 4 Presence of abdominal pain in subjects on RP-G28 reporting lactose tolerance in the patent global assessment

From: Improving lactose digestion and symptoms of lactose intolerance with a novel galacto-oligosaccharide (RP-G28): a randomized, double-blind clinical trial

  Abdominal pain No abdominal pain % with symptoms
Baseline 11 0 100%
Day 36 4 7 36%
Day 66 2 9 18%